Allogene Therapeutics Reports First Quarter 2020 Financial Results

Go back to Allogene Therapeutics Reports First Quarter 2020 Financial Results
(NASDAQ: ALLO) Delayed: 1.88 -0.09 (4.57%)
Previous Close $1.97    52 Week High
Open $1.97    52 Week Low
Day High $2.00    P/E N/A 
Day Low $1.86    EPS
Volume 5,521,410